Skip to content

Tolrestat

ALIMENTARY TRACT AND METABOLISM

Also known as: alredase, AY-27773, lorestat, tolrestatin

YEAR INTRODUCED approvedATC A10XA01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tolrestat is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1989. DrugCentral lists 9 molecular targets, including Akr1b1, AKR1B1 and AKR1B1. Recorded indications include Diabetic complication.

  • Molecular targets: Akr1b1, AKR1B1, AKR1B1 and AKR1B1 (9 listed in DrugCentral).
  • Indications: Diabetic complication.
  • ATC code: A10XA01 (Aldose reductase inhibitors).
  • Molecular formula: C16H14F3NO3S; molecular weight 357.35 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Diabetic complication

Mechanism & targets

Molecular targets (9)

TargetGeneActionActivity
Aldose reductaseAkr1b1unknownIC50 8.70
Aldose reductaseAKR1B1inhibitorIC50 8.51
Aldose reductaseAKR1B1unknownIC50 7.82
Aldose reductaseAKR1B1unknownIC50 7.48
Aldo-keto reductase family 1 member B10AKR1B10unknownKi 7.30
Alcohol dehydrogenase [NADP(+)]AKR1A1unknownIC50 6.27
Alcohol dehydrogenase [NADP(+)]AKR1A1unknownIC50 6.14
Alcohol dehydrogenase [NADP(+)]Akr1a1unknownIC50 5.92
Aldo-keto reductase family 1 member C21Akr1c21unknownKi 4.66

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1989-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
A10XA01ALIMENTARY TRACT AND METABOLISM › DRUGS USED IN DIABETES › OTHER DRUGS USED IN DIABETES › Aldose reductase inhibitors

Chemical structure

Molecular formulaC16H14F3NO3S
Molecular weight357.35 g/mol
CAS number82964-04-3
InChIKeyLUBHDINQXIHVLS-UHFFFAOYSA-N
PubChem CID53359
COC1=CC=C2C(=CC=CC2=C1C(F)(F)F)C(=S)N(C)CC(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tolrestat used for?

DrugCentral lists the following indications for Tolrestat: Diabetic complication.

How does Tolrestat work?

Its molecular targets in DrugCentral include Akr1b1, AKR1B1 (inhibitor), AKR1B1 and AKR1B1.

When was Tolrestat first approved?

Tolrestat was first approved by the YEAR INTRODUCED in 1989.

What is the chemical formula of Tolrestat?

Tolrestat has the molecular formula C16H14F3NO3S and a molecular weight of 357.35 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1989-01-01
AgencyYEAR INTRODUCED
Targets9
Indications1
FormulaC16H14F3NO3S
DrugCentral ID2704
Interactive profile